skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Non-CMV Herpes

(Last updated:11/1/2012; last reviewed:11/1/2012)

Non-CMV Herpes
Member Financial Disclosure
Company Relationship
Casper, Corey
University of Washington School of Medicine Centocor Research Support
Janssen Pharmaceuticals
Consultant, Research Support
Johnson & Johnson
Research Support
Sanofi Pasteur Research Support
Gnann, John*
University of Alabama at Birmingham
Baxter DSMB Member
BioCryst DSMB Member
Chimerix Consultant
GlaxoSmithKline
DSMB Member
Inhibitex Research Support
Macrogenics DSMB Member
Merck DSMB Member, Consultant
Valeant Consultant
Kimberlin, David
University of Alabama at Birmingham
Cellex Research Support
Cubist Research Support
GlaxoSmithKline
Research Support
Leone, Peter
University of North Carolina
Abbott Advisory Board, Research Support, Speaker’s Bureau
Genocea Research Support
GlaxoSmithKline
Consultant, Research Support, Speaker’s Bureau
Novartis Advisory Board, Research Support
Ortho-Clinical Diagnostics
Advisory Board, Consultant
Wald, Anna
University of Washington School of Medicine
AiCuris Consultant
Agenus Consultant
Astellas Consultant
Gilead Research Support
Up To Date Other
Virulite Consultant
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.